Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats
The blood-brain barrier (BBB) is often a limiting factor for getting drugs in the brain. Bypassing the BBB by intranasal (IN), or also called nose to brain (NTB), route is an interesting and frequently investigated concept for brain drug delivery. However, despite the body of evidence for IN drug de...
Saved in:
Main Authors: | Deborah Dhuyvetter (Author), Fetene Tekle (Author), Maxim Nazarov (Author), Rob J. Vreeken (Author), Herman Borghys (Author), Frederik Rombouts (Author), Ilse Lenaerts (Author), Astrid Bottelbergs (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ion-Triggered In Situ Gelling Nanoemulgel as a Platform for Nose-to-Brain Delivery of Small Lipophilic Molecules
by: Sreeharsha Nagaraja, et al.
Published: (2021) -
Small Molecule Drugs Targeting Viral Polymerases
by: Deborah Palazzotti, et al.
Published: (2024) -
Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules
by: Yan-Chuang Han, et al.
Published: (2016) -
Small-molecule agents for cancer immunotherapy
by: Fang Wang, et al.
Published: (2024) -
Small Molecule Inhibitors of CRM1
by: Bibiana I. Ferreira, et al.
Published: (2020)